Elevated insulin, proinsulin and insulin-like growth factor-binding protein-1 in liver disease

Growth Hormone and IGF Research

Volumn 13, Issue 6, 2003, Pages 316-321

  Hwang, David L ^a,c   Huang, Shiao Ping ^a   Lan, Wuu Shyang ^b   Lee, Phillip D K ^c,d  

^a FOOYIN UNIVERSITY   (Taiwan)

^b YUAN'S GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Cirrhosis; Hepatocellular carcinoma; IGFBP 1; Insulin; Liver disease; Proinsulin

Indexed keywords

INSULIN; PROINSULIN; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; AGED; ARTICLE; CLEARANCE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER METABOLISM; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION;

EID: 0345602043     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00042-X     Document Type: Article

References (40)

1. P.D.K. Lee, C.A. Conover, D.R. Powell, Regulation and function of insulin-like growth factor-binding protein-1, Proc. Soc. Exp. Biol. Med. 204 (1993) 4-29.
2. P.D.K. Lee, L.C. Giudice, C.A. Conover, D.R. Powell, Insulin-like growth factor binding protein-1: recent findings and new directions, Proc. Soc. Exp. Biol. Med. 216 (1997) 319-357.
3. M.S. Lewitt, G.S. Denyer, G.J. Cooney, R.C. Baxter, Insulin-like growth factor-binding protein-1 modulates blood glucose levels, Endocrinology 129 (1991) 2254-2256.
4. C.A. Conover, P.D.K. Lee, J.A. Kanaley, J.T. Clarkson, M.D. Jensen, Insulin regulation of insulin-like growth factor binding protein-1 in obese and non-obese humans, J. Clin. Endocrinol. Metab. 74 (1992) 1355-1360.
5. D. Mesotten, P.J.D. Delhanty, F. Vanderhoydonc, K.V. Hardman, F. Weekers, R.C. Baxter, G. Van der Berghe, Regulation of insulin-like growth factor binding protein-1 during protracted critical illness, J. Clin. Endocrinol. Metab. 87 (2002) 5516-5523.
6. D.R. Powell, S.K. Durham, F. Liu, B.K. Baker, P.D.K. Lee, S.K. Watkins, P.G. Campbell, E.D. Brewer, R.L. Hintz, R.J. Hogg, The IGF axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group, J. Clin. Endocrinol. Metab. 83 (1998) 1654-1661.
7. A. Donaghy, R. Ross, A. Gimson, S.C. Hughes, J. Holly, R. Williams, Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease, Hepatology 21 (1995) 680-688.
8. S. Moller, A. Juul, U. Becker, A. Flyvbjerg, N.E. Skakkebaek, J.H. Henriksen, Concentrations, release and disposal of insulin-like growth factor (IGF)-binding proteins, IGF-I and growth hormone in different vascular beds in patients with cirrhosis, J. Clin. Endocrinol. Metab. 80 (1995) 1148-1157.
9. R.J. Ross, J. Rodriguez-Arnao, A. Donaghy, J. Bentham, A. Clark, J. Holly, R. Williams, A. Gimson, Expression of IGFBP-1 in normal and cirrhotic human livers, J. Endocrinol. 141 (1994) 377-382.
10. R.I. Holt, P.A. Crossey, J.S. Jones, A.J. Baker, B. Portmann, J.P. Miell, Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediataric liver disease, Hepatology 26 (1997) 1600-1606.
11. E.-M. Rutanen, T. Karkkainen, C. Lundqvist, F. Pekonen, O. Ritvos, P. Tanner, M. Welin, T. Weber, Monoclonal antibodies to the 27-34 K insulin-like growth factor binding protein, Biochem. Biophys. Res. Commun. 152 (1988) 208-215.
12. J.M. Gibson, M. Westwood, F.F. Lauszus, J.G. Klebe, A. Flyvbjerg, A. White, Phosphorylated insulin-like growth factor binding protein1 is increased in pregnant diabetic subjects, Diabetes 48 (1999) 321-326.
13. P.D.K. Lee, S.K. Durham, V. Martinez, O. Vasconez, D.R. Powell, J. Guevara-Aguirre, Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone, J. Clin. Endocrinol. Metab. 82 (1997) 2266-2274.
14. D.R. Powell, F. Liu, B.K. Baker, P.D.K. Lee, R.L. Hintz, Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failure, Pediatr. Nephrol. 10 (1996) 343-347.
15. J. Kratzsch, W.F. Blum, F. Schenker, F. Keller, Regulation of growth hormone (GH), insulin-like growth factor (IGF) I, IGF binding proteins-1,-2,-3 and GH binding protein during progress of liver cirrhosis, Exp. Clin. Endocrinol. Diabetes 103 (1995) 285-291.
16. J. Min, H. Yu, H. Yan, L. He, H. Liu, C. Zhao, The growth hormone axis and insulin-like growth factors axis in liver failure patients, Zhonghua Gan Zang Bing Za Zhi 9 (Suppl.) (2001) 76-78.
17. S. Ormarsdottir, O. Ljunggren, H. Mallmin, H. Olofsson, W.F. Blum, L. Loof, Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density, Liver 21 (2001) 123-128.
18. E. Shmueli, J.P. Miell, M. Stewart, K.G. Alberti, C.O. Record, High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance, Hepatology 24 (1996) 127-133.
19. M.M. Weber, C.J. Auernhammer, P.D.K. Lee, D. Engelhardt, R. Zachoval, Insulinlike growth factors and insulinlike growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation, Horm. Res. 57 (2002) 105-112.
20. J. Lee, L. Greenbaum, B.A. Haber, D. Nagle, V. Lee, V. Miles, K.L. Mohn, M. Bucan, R. Taub, Structure and localization of the IGFBP-1 gene and its expression during liver regeneration, Hepatology 19 (1994) 656-665.
21. S.G. Gray, T. Erikkson, C. Ekström, S. Holm, D. von Schweinitz, P. Kogner, B. Sandstedt, T. Pietsch, T.J. Ekström, Altered expression of members of the IGF-axis in hepatoblastomas, Br. J. Cancer 82 (2000) 1561-1567.
22. R.J.M. Ross, S.L. Chew, L. D'Souza Li, M. Yateman, J. Rodriguez-Arnao, A. Gimson, J. Holly, C. Camacho-Hubner, Expression of IGF-I and IGF-binding protein genes in cirrhotic liver, J. Endocrinol. 149 (1996) 209-216.
23. Y. Gong, L. Cui, G.Y. Minuk, The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma, Mol. Cell. Biochem. 207 (2000) 101-104.
24. N. Kondoh, T. Wakatsuki, A. Ryo, A. Hada, T. Aihara, S. Horiuchi, N. Goseki, O. Matsubara, K. Takenaka, M. Shichita, K. Tanaka, M. Shuda, M. Yamamoto, Identification and characterization of genes associated with human hepatocellular carcinogenesis, Cancer Res. 59 (1999) 4990-4996.
25. N. Barzilai, P. Cohen, E. Karnieli, R. Enat, O. Epstein, J. Owen, N. McIntyre, In vivo insulin action in hepatocellular and cholestatic liver cirrhosis, J. Endocrinol. Invest. 14 (1991) 727-735.
26. A.V. Greco, G. Mingrone, A. Mari, E. Capristo, M. Manco, G. Gasbarrini, Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions, Gut 51 (2002) 870-875.
27. M. Kato, H. Asano, Y. Miwa, M. Tajika, M. Yamato, E. Tomita, K. Tokuyama, Y. Muto, H. Moriwaki, Both insulin sensitivity and glucose sensitivity are impaired in patients with non-diabetic liver cirrhosis, Hepatol. Res. 17 (2000) 93-101.
28. E. Kiwanuka, R. Barrazoni, P. Tessari, Glucose kinetics and spanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects, Diabetes Nutr. Metab. 14 (2001) 315-324.
29. Y.T. Kruszynska, J. Munro, P.D. Home, N. McIntyre. Twenty-four hour C-peptide and insulin secretion rates and diurnal profiles of glucose, lipids and intermediary metabolites in cirrhosis, Clin. Sci. 83 (1992) 597-605.
30. Y.T. Kruszynska, S. Goulas, N. Wollen, N. McIntyre, Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients, J. Hepatol. 28 (1998) 280-291.
31. M.J. Müller, Are patients with cirrhosis "glucose resistant"?, J. Hepatol. 22 (1995) 504-507.
32. M.H. Muller, O. Willmann, A. Rieger, A. Fenk, O. Selberg, H.U. Lautz, M. Burger, H.J. Balks, A. von zur Muhlen, F.W. Schmidt, Meachism of insulin resistance associated with liver cirrhosis, Gastroenterology 102 (1992) 2033-3041.
33. Y.T. Kruszynska, D.S. Harry, V. Mohamed-Ali, P.D. Home, J.S. Yudkin, N. McIntyre, The contribution of proinsulin and des-31,32 proinsulin to the hyperinsulinemia of diabetic and nondiabetic cirrhotic patients, Metabolism 44 (1995) 254-260.
34. N. Custro, A. Carrocio, A. Ganci, V. Scafidi, P. Campagna, L. Di Prima, G. Montalto, Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis, Diabetes Metab. 27 (2001) 476-481.
35. C. Del Vecchio Blanco, S. Gentile, R. Marmo, L. Carbone, M. Coltorti, Alterations of glucose metabolism in chronic liver disease, Diabetes Res. Clin. Pract. 8 (1990) 29-36.
36. J.-C. Wu, W.H. Daughaday, S.-D. Lee, T.S. Hsiao, C.-K. Chou, H.-D. Lin, Y.-T. Tsai, B.N. Chiang, Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia, J. Lab. Clin. Med. 112 (1998) 589-594.
37. F. Wong, A. Logan, L. Blendis, Hyperinsulinemia in pre-ascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity, Hepatology 23 (1996) 414-422.
38. K. Saito, S. Inoue, T. Saito, S. Kiso, N. Ito, S. Tamura, H. Watanabe, H. Takeda, H. Misawa, H. Togashi, Y. Matsuzawa, S. Kawata, Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma, Gut 51 (2002) 100-104.
39. H.B. El-Serag, J.E. Everhart, Diabetes increases the risk of acute hepatic failure, Gastroenterology 122 (2002) 1822-1828.
40. A. Donaghy, Issues of malnutrition and bone diseases in patients with cirrhosis, J. Gastroenterol. Hepatol. 17 (2002) 462-477.